Keros Therapeutics Reports Second Quarter 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/29/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to Keros Therapeutics Reports Second Quarter 2026 Financial Results
(NASDAQ: KROS) Delayed: 11.03 -0.2 (1.78%)
Previous Close $11.23    52 Week High $ 
Open $11.15    52 Week Low $ 
Day High $11.16    P/E N/A 
Day Low $10.58    EPS $ 
Volume 328,289